S

Active Director Managing Director DIN 07262489
DIN 07262489 First appointment Sep 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Sanil

Data last updated:

Sanil is a Managing Director at Litman Pharmaceuticals Private Limited (since 2015). The company operates in Chemicals. Litman Pharmaceuticals Private Limited reported revenue of ₹8.7 Lakh (FY 2024).

DIN 07262489
Primary Designation Managing Director
Industry Chemicals
First Appointment 15 Sep 2015
Oldest Company Age 11 yrs
Largest company Litman Pharmaceuticals Private Limited · ₹8.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director15 Sep 20152015₹8.7 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Litman Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanil

Sanil currently holds 1 directorship: Litman Pharmaceuticals Private Limited (Managing Director, since 15 Sep 2015, revenue ₹8.7 Lakh (FY 2024)).

Sanil was first appointed on 15 Sep 2015 as Managing Director at Litman Pharmaceuticals Private Limited.

The current boards of Sanil's companies include Abhishek Mudoor (Litman Pharmaceuticals Private Limited), Ardra Vijayan (Litman Pharmaceuticals Private Limited), Midhun Raj V C (Litman Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available